Quick Answer
Oscar Health, Inc. reported Stockholders Equity of $977.65 million for the year ending 2025.
- Oscar Health, Inc. showed a decrease of -3.5% in Stockholders Equity from 2024 to 2025.
- This data is from Oscar Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: -$945.14 million | Q1 2020: -$1.03 billion | Q2 2020: -$1.07 billion | Q3 2020: -$1.14 billion | Q1 2021: $1.79 billion | Q2 2021: $1.73 billion | Q3 2021: $1.55 billion | Q1 2022: $1.33 billion | Q2 2022: $1.25 billion | Q3 2022: $1.08 billion | Q1 2023: $929.60 million | Q2 2023: $949.70 million | Q3 2023: $919.48 million | Q1 2024: $1.03 billion | Q2 2024: $1.14 billion | Q3 2024: $1.16 billion | Q1 2025: $1.33 billion | Q2 2025: $1.16 billion | Q3 2025: $1.02 billion.
- Over the full 6 years of available data (2020 to 2025), Oscar Health, Inc.'s Stockholders Equity has grown by 175.4%.
- Historical annual values: Fiscal year 2025: $977.65 million | Fiscal year 2024: $1.01 billion | Fiscal year 2023: $803.97 million | Fiscal year 2022: $890.38 million | Fiscal year 2021: $1.39 billion | Fiscal year 2020: -$1.30 billion.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: